(Radio)Theranostic Patient Management in Oncology Exemplified by Neuroendocrine Neoplasms, Prostate Cancer, and Breast Cancer

The role of nuclear medicine in the management of oncological patients has expanded during last two decades. The number of radiopharmaceuticals contributing to the realization of theranostics/radiotheranostics in the context of personalized medicine is increasing. This review is focused on the examp...

Full description

Bibliographic Details
Main Author: Irina Velikyan
Format: Article
Language:English
Published: MDPI AG 2020-03-01
Series:Pharmaceuticals
Subjects:
pet
Online Access:https://www.mdpi.com/1424-8247/13/3/39
id doaj-88dce6cba3d548238e90feb16ba6357b
record_format Article
spelling doaj-88dce6cba3d548238e90feb16ba6357b2020-11-25T03:50:46ZengMDPI AGPharmaceuticals1424-82472020-03-011333910.3390/ph13030039ph13030039(Radio)Theranostic Patient Management in Oncology Exemplified by Neuroendocrine Neoplasms, Prostate Cancer, and Breast CancerIrina Velikyan0Science for Life Laboratory, Department of Medicinal Chemistry, Uppsala University, 751 83 Uppsala, SwedenThe role of nuclear medicine in the management of oncological patients has expanded during last two decades. The number of radiopharmaceuticals contributing to the realization of theranostics/radiotheranostics in the context of personalized medicine is increasing. This review is focused on the examples of targeted (radio)pharmaceuticals for the imaging and therapy of neuroendocrine neoplasms (NENs), prostate cancer, and breast cancer. These examples strongly demonstrate the tendency of nuclear medicine development towards personalized medicine.https://www.mdpi.com/1424-8247/13/3/39(radio)theranosticssomatostatinneuroendocrine neoplasmsprostate cancerbreast cancerpsmapetspectgallium-68lutetium-177
collection DOAJ
language English
format Article
sources DOAJ
author Irina Velikyan
spellingShingle Irina Velikyan
(Radio)Theranostic Patient Management in Oncology Exemplified by Neuroendocrine Neoplasms, Prostate Cancer, and Breast Cancer
Pharmaceuticals
(radio)theranostics
somatostatin
neuroendocrine neoplasms
prostate cancer
breast cancer
psma
pet
spect
gallium-68
lutetium-177
author_facet Irina Velikyan
author_sort Irina Velikyan
title (Radio)Theranostic Patient Management in Oncology Exemplified by Neuroendocrine Neoplasms, Prostate Cancer, and Breast Cancer
title_short (Radio)Theranostic Patient Management in Oncology Exemplified by Neuroendocrine Neoplasms, Prostate Cancer, and Breast Cancer
title_full (Radio)Theranostic Patient Management in Oncology Exemplified by Neuroendocrine Neoplasms, Prostate Cancer, and Breast Cancer
title_fullStr (Radio)Theranostic Patient Management in Oncology Exemplified by Neuroendocrine Neoplasms, Prostate Cancer, and Breast Cancer
title_full_unstemmed (Radio)Theranostic Patient Management in Oncology Exemplified by Neuroendocrine Neoplasms, Prostate Cancer, and Breast Cancer
title_sort (radio)theranostic patient management in oncology exemplified by neuroendocrine neoplasms, prostate cancer, and breast cancer
publisher MDPI AG
series Pharmaceuticals
issn 1424-8247
publishDate 2020-03-01
description The role of nuclear medicine in the management of oncological patients has expanded during last two decades. The number of radiopharmaceuticals contributing to the realization of theranostics/radiotheranostics in the context of personalized medicine is increasing. This review is focused on the examples of targeted (radio)pharmaceuticals for the imaging and therapy of neuroendocrine neoplasms (NENs), prostate cancer, and breast cancer. These examples strongly demonstrate the tendency of nuclear medicine development towards personalized medicine.
topic (radio)theranostics
somatostatin
neuroendocrine neoplasms
prostate cancer
breast cancer
psma
pet
spect
gallium-68
lutetium-177
url https://www.mdpi.com/1424-8247/13/3/39
work_keys_str_mv AT irinavelikyan radiotheranosticpatientmanagementinoncologyexemplifiedbyneuroendocrineneoplasmsprostatecancerandbreastcancer
_version_ 1724490705419632640